v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Information [Abstract]  
Segment Information

13. Segment Information

 

The Company’s Chief Executive Officer is the chief operating decision maker, or CODM. The CODM allocates resources and assesses performance of the Company’s single reportable segment by regularly reviewing the segment net income (loss) that also is reported on the condensed consolidated statements of operations and comprehensive loss as consolidated net income (loss). The measure of segment assets is reported on the balance sheet as total consolidated assets.

 

The following table sets forth information about the Company’s single reportable segment and the significant expenses reviewed by the CODM, including a reconciliation to consolidated net income (loss):

 

   For the Three Months Ended
June 30,		   For the Six Months Ended
June 30,		 
   2026   2025   2026   2025 
Research and development expenses:                
TARA-002 in NMIBC  $6,848   $4,898   $12,686   $8,455 
TARA-002 in LMs   852    477    1,660    1,027 
IV Choline Chloride   2,726    1,852    4,946    4,367 
Other research and development   6,165    3,317    10,449    5,651 
General and administrative expenses   5,349    5,139    10,466    9,474 
Stock-based compensation expense   1,384    903    2,746    1,736 
Income (loss) from operations   (23,324)   (16,586)   (42,953)   (30,710)
Other income (expense), net   1,656    1,626    3,503    3,836 
Segment net income (loss)   (21,668)   (14,960)   (39,450)   (26,874)
Adjustments and reconciling items   
-
    
-
    
-
    
-
 
Net income (loss)  $(21,668)  $(14,960)  $(39,450)  $(26,874)

 

Other research and development expenses consist of personnel-related expenses as well as other external research and development expenses that are not directly attributable to a specific program.